MIME News - Monday 21 March
If you would like a story added to our next newsletter please contact Susan Newland at mime-enquiries@monash.edu
Welcome to 2016
The executive team at MIME have spent the first few months of 2016 planning and preparing for the launch of the 2016 MIME Seed Fund round, which officially opens with Phase 1 applications on Friday, 8 April. Following on from the success of the 2015 MIME Seed Fund round, a further $500,000 will be available in 2016, with up to $50,000 available per project.
In the first quarter of this year MIME has hosted visits from several companies, international delegations and visitors from interstate universities. We have also launched our MIME seminar series with additional seminars throughout the year to be advertised through our regular MIME News bulletin. We hope you will be able to join various activities and collaborations throughout the year.
2016 MIME Affinity Meetings
MIME Affinity Meetings provide an opportunity for clinician researchers at our hospital sites to connect to researchers with enabling expertise in the areas of engineering, IT, design, science and biomedicine, etc. The meetings aim to foster new collaborative connections for clinicians and researchers interested in developing leading edge medical technologies.

In April 2016, MIME will be facilitating two Affinity Meetings which have been scheduled to coincide with Phase 1 of the MIME seed funding process, - i.e. the Call to Clinicians to nominate areas of significant unmet clinical need that could potentially be addressed by engineering or IT innovation.
Clinician researchers from the Faculty of Medicine, Nursing and Health Sciences are invited to give a 5 minute presentation outlining a clinical need or opportunity they are willing to champion. Please advise susan.newland@monash.edu or complete the appropriate registration form below if you wish to present. Engineering, IT & other researchers seeking a clinical collaborator are also invited to give a 5 minute presentation on aspects of their research that could make a significant difference to clinical diagnostics, treatment or care.
Engineering, IT and other MIME researchers are strongly encouraged to attend these events, to identify new opportunities to apply your expertise, and meet potential clinical collaborators. Networking time will be available. Researchers attending these events should then be well positioned to respond to Phase 2 of the MIME seed fund process - the call for Engineering or IT-enabled R&D programs addressing unmet clinical needs.
Researchers wishing to attend the Affinity Meetings should complete the online form below. MIME will provide transport between the Clayton site and the Affinity meetings.
Researchers from MIME partner organisations i.e. CSIRO, Hudson Institute and BakerIDI are also welcome to attend the MIME Affinity meetings.
The first meeting is scheduled for Wednesday, 20 April at Monash Medical Centre from 2.00pm - 4.00pm. If you would like to attend or present at this meeting please complete the registration form by Wednesday, 13 April.
The second meeting is scheduled for Thursday, 28 April at the Alfred from 9.00am - 11.00am, If you would like to attend or present at this meeting please complete the registration form by Thursday, 21 April.
Applications for clinicians to submit unmet clinical needs for the 2016 MIME Seed Fund round will open on Friday, 8 April. Applications should be submitted through the link on our website under the MIME Seed Funding tab. Up to $50,000 per project may be requested.

In April 2016, MIME will be facilitating two Affinity Meetings which have been scheduled to coincide with Phase 1 of the MIME seed funding process, - i.e. the Call to Clinicians to nominate areas of significant unmet clinical need that could potentially be addressed by engineering or IT innovation.
Clinician researchers from the Faculty of Medicine, Nursing and Health Sciences are invited to give a 5 minute presentation outlining a clinical need or opportunity they are willing to champion. Please advise susan.newland@monash.edu or complete the appropriate registration form below if you wish to present. Engineering, IT & other researchers seeking a clinical collaborator are also invited to give a 5 minute presentation on aspects of their research that could make a significant difference to clinical diagnostics, treatment or care.
Engineering, IT and other MIME researchers are strongly encouraged to attend these events, to identify new opportunities to apply your expertise, and meet potential clinical collaborators. Networking time will be available. Researchers attending these events should then be well positioned to respond to Phase 2 of the MIME seed fund process - the call for Engineering or IT-enabled R&D programs addressing unmet clinical needs.
Researchers wishing to attend the Affinity Meetings should complete the online form below. MIME will provide transport between the Clayton site and the Affinity meetings.
Researchers from MIME partner organisations i.e. CSIRO, Hudson Institute and BakerIDI are also welcome to attend the MIME Affinity meetings.
The second meeting is scheduled for Thursday, 28 April at the Alfred from 9.00am - 11.00am, If you would like to attend or present at this meeting please complete the registration form by Thursday, 21 April.
Applications for clinicians to submit unmet clinical needs for the 2016 MIME Seed Fund round will open on Friday, 8 April. Applications should be submitted through the link on our website under the MIME Seed Funding tab. Up to $50,000 per project may be requested.
Launch of the 2016 MIME Seed Fund Round
The MIME Seed Fund was established to accelerate the development of new medical technologies that address significant unmet clinical needs. The first round was launched in 2015 with $933,386 seed funding awarded to initiate 25 new collaborative projects. As a result, we are now launching a 2016 round, which will commence on Friday, 8 April with the opening of the call to clinicians to submit unmet clinical needs.
The 2016 round aims to continue building on the purpose of the 2015 round, which was designed to lay the foundations for the collaborative framework of MIME, by encouraging early clinician involvement in identifying areas of significant clinical need enabling our research to be directed to areas where it can deliver the greatest impact. Additionally, we are aiming to continue building and strengthening collaborative relationships between MNHS clinicians in Monash's partner hospitals and researchers in the Faculties of Engineering and IT, as well as reaching out to researchers in other disciplines and partner organisations.
Like the 2015 round, there will be two stages to the application process: an initial call to clinicians to define areas of unmet clinical need, followed by an invitation to all Monash staff to respond with proposed solutions. All Monash staff are eligible to participate in the multidisciplinary ‘solution' teams. Researchers from MIME partner institutions are also invited to participate as members of the collaborative teams.
Following on from the success of 2015, there will be up to $500,000 available in the 2016 funding round. Applications may be for any amount between $10,000 - $50,000. The funding will be directed to projects that can achieve a meaningful outcome within 12 - 18 months, e.g. proof-of-concept data or initial prototype. The seed funding is aimed at progressing a project to the point that the research team is well positioned to then secure external funding from industry or grants to progress the next phase of the R&D.
Further details regarding the 2016 MIME Seed Fund round including key dates are available on the MIME website.
The 2016 round aims to continue building on the purpose of the 2015 round, which was designed to lay the foundations for the collaborative framework of MIME, by encouraging early clinician involvement in identifying areas of significant clinical need enabling our research to be directed to areas where it can deliver the greatest impact. Additionally, we are aiming to continue building and strengthening collaborative relationships between MNHS clinicians in Monash's partner hospitals and researchers in the Faculties of Engineering and IT, as well as reaching out to researchers in other disciplines and partner organisations.
Like the 2015 round, there will be two stages to the application process: an initial call to clinicians to define areas of unmet clinical need, followed by an invitation to all Monash staff to respond with proposed solutions. All Monash staff are eligible to participate in the multidisciplinary ‘solution' teams. Researchers from MIME partner institutions are also invited to participate as members of the collaborative teams.
Following on from the success of 2015, there will be up to $500,000 available in the 2016 funding round. Applications may be for any amount between $10,000 - $50,000. The funding will be directed to projects that can achieve a meaningful outcome within 12 - 18 months, e.g. proof-of-concept data or initial prototype. The seed funding is aimed at progressing a project to the point that the research team is well positioned to then secure external funding from industry or grants to progress the next phase of the R&D.
Further details regarding the 2016 MIME Seed Fund round including key dates are available on the MIME website.
Update on PhD Scholarships
The portfolio of available PhD project topics has been established via the 2015 seed fund process. For unmet clinical needs that require a challenging longer term research program, appropriate PhD projects were scoped by the multidisciplinary solution teams.
We are now actively seeking applications from prospective students, interested in carrying out world-leading medical engineering research in these project areas. These students will have the benefit of a truly multidisciplinary learning experience, being co-supervised by both the clinical champion and the leading STEM academics and mentored by the broader research team.
16 PhD living allowance scholarships have been made available for the MIME projects through the generous contributions of the Faculty of Engineering and the Faculty of IT, Central Clinical School, School of Public Health and Preventive Medicine, School of Clinical Science Monash Health, Monash Health, the Alfred Foundation, Alfred Health Research Trust and CSIRO.
Further information is available on the MIME website.
Funding
Ramaciotti Health Investment Grants
Ramaciotti Medal for Excellence in Biomedical Research
As trustee of the Ramaciotti Foundations, Perpetual would like to advise that applications are now open for the 2016 Ramaciotti Awards.
2016 Ramaciotti Awards
Ramaciotti Health Investment Grants of up to $150,000 are awarded to individuals in universities, public hospitals or institutes for a contribution towards the undertaking of health or medical research, with the potential path to clinical application within five years. A Health Investment grant is intended to provide enabling research support for an autonomous, early career investigator who is taking, or has recently taken, a substantive position.
Ramaciotti Medal for Excellence in Biomedical Research
The Ramaciotti Medal is an annual award of $50,000. The Medal honours an individual who has made an outstanding discovery (or discoveries) in clinical or experimental biomedical research that has had an important impact on biomedical science, clinical science, or the way in which healthcare is delivered.
APPLICATIONS CLOSE 5PM (AEST) ON FRIDAY 27 MAY 2016
For more information on the Awards, conditions, and how to apply, please visit the Ramaciotti website.
If you intend to apply for a Ramaciotti Award, please advise the Faculty Research Office (medicine.research@monash.edu), as external editorial assistance on your application is available through Monash University's Prizes & Awards Strategy.
The CASS Foundation
The objective of The CASS Foundation is to fund programs and projects which have the capacity to provide a benefit to a significant sector of the Australian community.
In the field of education, CASS has a preference for funding innovative, curriculum-based projects which are sustainable in the long term and which may have the potential to be exemplars for change. CASS also considers need and disadvantage in its grant-making decisions.
In medicine and science, CASS supports short term ‘proof of concept’ research in promising topic areas, which if validated, have the potential to attract longer-term funding and to contribute to better practice and delivery of services.
CASS travel grants fill a need for early career post-doctoral researchers to attend and participate in overseas conferences to further their professional development and establish contact with their international peers and research collaborators.
CASS provides annual grants for research and development in science and medicine. Each year the grant Guidelines and Application Form and process are reviewed in the light of past experience, changing circumstances and developments which might affect our prime focus. In 2015, the Foundation funded a further round of Grants in accordance with published Guidelines. A further round will be funded in 2016.
2016 Medicine/Science Grants round
The 2016 Medicine/Science grant round will open on 15th August 2016, when the online Application portal will become available. Further details regarding the CASS Foundation is available through their website.
Ramaciotti Medal for Excellence in Biomedical Research
As trustee of the Ramaciotti Foundations, Perpetual would like to advise that applications are now open for the 2016 Ramaciotti Awards.
2016 Ramaciotti Awards
Ramaciotti Health Investment Grants of up to $150,000 are awarded to individuals in universities, public hospitals or institutes for a contribution towards the undertaking of health or medical research, with the potential path to clinical application within five years. A Health Investment grant is intended to provide enabling research support for an autonomous, early career investigator who is taking, or has recently taken, a substantive position.
Ramaciotti Medal for Excellence in Biomedical Research
The Ramaciotti Medal is an annual award of $50,000. The Medal honours an individual who has made an outstanding discovery (or discoveries) in clinical or experimental biomedical research that has had an important impact on biomedical science, clinical science, or the way in which healthcare is delivered.
APPLICATIONS CLOSE 5PM (AEST) ON FRIDAY 27 MAY 2016
For more information on the Awards, conditions, and how to apply, please visit the Ramaciotti website.
If you intend to apply for a Ramaciotti Award, please advise the Faculty Research Office (medicine.research@monash.edu), as external editorial assistance on your application is available through Monash University's Prizes & Awards Strategy.
The CASS Foundation
The objective of The CASS Foundation is to fund programs and projects which have the capacity to provide a benefit to a significant sector of the Australian community.
In the field of education, CASS has a preference for funding innovative, curriculum-based projects which are sustainable in the long term and which may have the potential to be exemplars for change. CASS also considers need and disadvantage in its grant-making decisions.
In medicine and science, CASS supports short term ‘proof of concept’ research in promising topic areas, which if validated, have the potential to attract longer-term funding and to contribute to better practice and delivery of services.
CASS travel grants fill a need for early career post-doctoral researchers to attend and participate in overseas conferences to further their professional development and establish contact with their international peers and research collaborators.
CASS provides annual grants for research and development in science and medicine. Each year the grant Guidelines and Application Form and process are reviewed in the light of past experience, changing circumstances and developments which might affect our prime focus. In 2015, the Foundation funded a further round of Grants in accordance with published Guidelines. A further round will be funded in 2016.
The 2016 Medicine/Science grant round will open on 15th August 2016, when the online Application portal will become available. Further details regarding the CASS Foundation is available through their website.
MIME News - Friday 18 December 2015
If you would like a story added to our next newsletter please contact Susan Newland at mime-enquiries@monash.edu
A Message from the MIME Executive Team
As the year comes to a close, the MIME executive team members have spent some time reflecting on MIME's first year of operation. 2015 was both a busy and productive year for MIME. We focused strongly on building collaborative partnerships between our researchers and clinicians and the success of the 2015 MIME Seed Fund is a clear reflection of the relationships formed. We facilitated many industry meetings and worked on a variety of projects with all of you. We would like to thank all of our researchers and clinicians for their strong support, energy and enthusiasm for MIME and our initiatives. We wish you all a happy and safe holiday season and look forward to an exciting, challenging and rewarding 2016.
2015 MIME Seed Fund
The MIME seed fund was established to accelerate the development of new medical technologies that address significant unmet clinical needs. The 2015 MIME Seed Fund round was designed to lay the foundations for the collaborative framework of MIME, by encouraging early clinician involvement in identifying areas of significant clinical need, so that our research can be directed to areas where it can deliver greatest impact. The program aimed to build and strengthen collaborative relationships between MNHS clinicians in Monash's partner hospitals and researchers in the Faculties of Engineering and IT, as well as reaching out to researchers in other disciplines and partner organisations.
The 2015 MIME Seed Fund round proved to be an overwhelming success with approximately 80 applications for unmet clinical needs received as part of phase I of the program submitted by clinicians. As part of phase II of the program we received a large number of project responses from our researchers. As a result over $700 000 in seed funding was awarded.
We would like to thank all clinicians who submitted an unmet clinical need and all researchers who submitted a project proposal. We extend our congratulations to the successful project teams below. We look forward to the 2016 MIME Seed Fund round being as successful.
The 2015 MIME Seed Fund round proved to be an overwhelming success with approximately 80 applications for unmet clinical needs received as part of phase I of the program submitted by clinicians. As part of phase II of the program we received a large number of project responses from our researchers. As a result over $700 000 in seed funding was awarded.
We would like to thank all clinicians who submitted an unmet clinical need and all researchers who submitted a project proposal. We extend our congratulations to the successful project teams below. We look forward to the 2016 MIME Seed Fund round being as successful.
MIME 2015 Seed Funding Awardees
Clinical champion
|
Project title
|
Short description
|
Researchers from Eng/IT
|
Others
|
Hospital
|
|
MIME 2015 Seed Funding Awardees
|
||||||
Cardiovascular and lung disease
|
||||||
24
|
Dr Greg Szto, Dr David
Kannar
|
Blocked arteries
|
Develop novel
bio-absorbable stents
|
Professor Nick Birbilis (ENG), Professor Chris Davies (ENG), Professor
Laurence Meagher (ENG)
|
Dr Thilak Gunatillake (CSIRO), Dr Jerome Werkmeister (CSIRO)
|
Monash Health
|
65
|
Adjunct Professor Bruce Thompson
|
Asthma treatment
|
Development and testing of
a nebulizer with “dial up” particle size control that can target small
airways, improving the treatment of asthma
|
Dr Tuncay Alan (ENG), Associate Professor
Adrian Neild (ENG)
|
Alfred Health
|
|
Musculoskeletal disease
|
||||||
5
|
Professor Flavia Cicuttini
|
Hip arthritis
|
Develop
an assistive device to unload the hip joint, reduce pain and aid mobility
|
Dr Chao Chen (ENG)
|
Dr Anna Murphy (MH), Dr Hoam
Chung (ENG)
|
Alfred Health
|
14
|
Professor Peter Ebeling AO
|
Osteoporosis
|
Develop
wearable sensors to monitor forces at the hip and spine, to optimise exercise
regimes to improve bone density
|
Dr Mehmet Yuce (ENG), Dr Jean-Michel
Redoute (ENG)
|
Dr David Scott (MH), Professor Daphne Flynn (MADA), Mr Gene
Bawden (MADA)
|
Monash Health
|
59
|
Dr Elizabeth Sigston
|
Materials for maxillofacial reconstructive surgery
|
Development
of 3D printed materials for integration with bone in reconstructive surgery,
particularly for repair required as a result of cancer
|
Dr Andrey Molotnikov (ENG),
Professor George Simon (ENG), Professor Nick Birbilis (ENG) Professor Xinhua Wu (ENG),
Professor Chris Davies (ENG)
|
Monash Health
|
|
Neural, vision and mental health
|
||||||
36
|
Dr Steven Miller
|
Persistent pain
|
Develop
self-administered brain stimulation device for home-based management of
chronic pain
|
Dr Andrew Nunn (ENG)
|
Professor Daphne Flynn (MADA)
|
Alfred Health
|
Trauma, emergency and intensive care
|
||||||
17
|
Professor
Mark Fitzgerald
|
Chest trauma
|
Develop semi-automated device for emergency drainage of
blood in the chest cavity (pleural decompression device)
|
Professor
Wing Kong Chiu (ENG), Dr Chao Chen (ENG), Dr Scott Wordley (ENG)
|
Fei Bing
|
Alfred Health
|
18
|
Professor Mark Fitzgerald
|
Trauma resuscitation
|
Develop
wireless heads-up display for real-time decision support in trauma situations
|
Professor Wing Kong Chiu (ENG), Dr Chao
Chen (ENG), WH Ong
|
Professor Daphne Flynn (MADA), Mr Gene
Bawden (MADA)
|
Alfred Health
|
Cancer
|
||||||
12
|
Dr Daniel Croagh
|
Pancreatic cancer
|
Develop
a small, handheld diagnostic device to isolate circulating tumour cells
allowing non-invasive monitoring during personalised chemotherapy
|
Associate Professor Adrian Neild (ENG),
Dr Tuncay Alan (ENG)
|
Professor Brendan Jenkins (Hudson)
|
Monash Health
|
62
|
Professor Andrew Spencer
|
Multiple myeloma diagnostic tool
|
Develop
a diagnostic test for detecting circulating tumour DNA for use in primary
healthcare
|
Dr Andrew Rodda (ENG)
|
Dr Simon Corrie (ENG)
|
Alfred Health
|
Infectious disease
|
||||||
50
|
Professor
Anton Peleg
|
Hospital-acquired infections
|
Develop
surface coatings for medical devices that resist the attachment of organisms
and establishment of biofilms, particularly antibiotic resistance biofilms
|
Professor Laurence Meagher (ENG)
|
Dr Ana Traven (MNHS), Dr Katherine
Locock (CSIRO), Dr Yue Qu (MNHS)
|
Alfred Health
|
54
|
Dr Michelle Ananda-Rajah
|
Fungal diseases
|
Use
of electronic surveillance and data analytics to improve clinical risk
assessment and management of fungal diseases
|
Professor Geoff Webb (FIT), Dr Reza Haffari (FIT), Professor Tom
Drummond (ENG)
|
Alfred Health
|
|
80
|
Dr Tony Korman
|
Sepsis
|
Infrared-based
diagnostic tool for identification of early sepsis for point of use care
(primary healthcare)
|
Professor Wray Buntine (FIT)
|
Dr Bayden Wood (SCI), Michelle
Francis (MNHS), Dr Phil Heraud (MNHS), Mr David Perez Guaita (SCI)
|
Monash Health
|
Obstetrics
|
||||||
72
|
Professor
Euan Wallace
|
Still Birth
|
Development
of a simple device to monitor and report on foetal movements, to be worn
during late pregnancy
|
Professor Wenlong Cheng (ENG), Professor
George Simon (ENG), Professor Geoff Webb (FIT)
|
Dr Stephen Wang (MADA)
|
Monash Health
|
Surgical training and instrumentation
|
||||||
71
|
Dr Neil Vallance
|
Laryngoscope development
|
Development
of an improved laryngoscope
|
Dr Chao Chen
(ENG), Dr Bernard Chen (ENG)
|
Mr Mark Harrison (SCI)
|
Alfred Health
|
Health systems ICT
|
||||||
37
|
Professor Eric Morand
|
Clinical research database
|
Develop
web-based clinical research database to enable researchers to mine
de-identified clinical data from electronic medical records
|
Dr Yuan-Fang Li (FIT)
|
Dr Yong-Bin Kang (FIT), Ms Suong
Le (MH), Associate Professor Ronnie Ptasznik (MH), Professor James Cameron
(MH), Mr Ian Larmour (MH), Dr Adam West (MH), Earl Blessing (MH)
|
Monash Health
|
38b
|
Professor Eric Morand
(Morand, Ptasznik, Liu and Steinfeld) |
eReferrals
|
Assessment
and improvement of software for workflow management in hospital practice
|
Dr Joseph Liu (FIT), Dr Ron Steinfeld (FIT)
|
Associate Professor Ronnie Plasznik (MH), Professor Eric Morand,
(MH), Ms Suong Le (MH), Earl Blessing (MH)
|
Monash Health
|
Subscribe to:
Posts (Atom)